Clinical trials
Active, not recruiting Phase 3 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 4 |
| AstraZeneca | 4 |
| Genmab | 3 |
| Hoffmann-La Roche | 3 |
| Astellas Pharma Global Development, Inc. | 2 |
| Exelixis | 2 |
| Acerta Pharma BV | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Amgen | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 41 |
| Breast Neoplasms | 7 |
| Lymphoma, Non-Hodgkin | 5 |
| Recurrence | 5 |
| Colorectal Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Prostatic Neoplasms | 4 |
| Breast Diseases | 3 |
| Lymphoma | 3 |
| Neoplasms by Site | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.